• No results found

selective cyclooxygenase-2 inhibitor

The highly selective cyclooxygenase-2 inhibitor DFU is neuroprotective when given several hours after transient cerebral ischemia in gerbils

The highly selective cyclooxygenase-2 inhibitor DFU is neuroprotective when given several hours after transient cerebral ischemia in gerbils

... highly selective cyclooxygenase-2 inhibitor DFU (5,5-dimethyl-3-(3- fluorophenyl)-4-(4-methylsulphonyl) phenyl-2(5H)-furanone) (Merck Frosst, Quebec, Canada) was administered orally (10 ...

10

Association of maternal pancreatic function and foetal growth in rats treated with DFU, a selective cyclooxygenase-2 inhibitor

Association of maternal pancreatic function and foetal growth in rats treated with DFU, a selective cyclooxygenase-2 inhibitor

... a selective COX-2 inhibitor, in spite of the consti- tutive expression of the inducible isoform in the pan- ...another selective COX-2 inhibitor, namely DuP-697, which did not ...

9

Antitumor activity of the selective cyclooxygenase-2 inhibitor, celecoxib, on breast cancer in Vitro and in Vivo

Antitumor activity of the selective cyclooxygenase-2 inhibitor, celecoxib, on breast cancer in Vitro and in Vivo

... Celecoxib may exert an inhibitory effect on the en- hanced radiation-induced G2/M arrest in the COX-2- overexpressing cells. This effect may allow the arrested cells to enter mitosis and die after radiation [31]. ...

8

Selective cyclooxygenase-2 inhibitor use and progression of renal function in patients with chronic kidney disease: a single-center retrospective cohort study

Selective cyclooxygenase-2 inhibitor use and progression of renal function in patients with chronic kidney disease: a single-center retrospective cohort study

... The limitations of this study include: 1) The obser- vational study design – so no kidney biopsy was used to diagnose causative renal diseases, such as acute ischemic tubular necrosis and ATIN; 2) The study did ...

6

Antitumor enhancement of celecoxib, a selective Cyclooxygenase-2 inhibitor, in a Lewis lung carcinoma expressing Cyclooxygenase-2

Antitumor enhancement of celecoxib, a selective Cyclooxygenase-2 inhibitor, in a Lewis lung carcinoma expressing Cyclooxygenase-2

... To further improve tumor response and reduce normal tissue toxicity from radiotherapy or chemoradiotherapy, many novel approaches have investigated several agents in preclinical and clinical settings. These approaches ...

9

EXPERIMENTAL ANTIBACTERIAL ACTIVITY OF SELECTIVE CYCLOOXYGENASE ANTAGONIST

EXPERIMENTAL ANTIBACTERIAL ACTIVITY OF SELECTIVE CYCLOOXYGENASE ANTAGONIST

... selected selective cyclooxygenase-2 ...of selective COX-2 (meloxicam,celecoxib,valdicoxib and ...conclusion selective cyclooxygenase (cox-2) inhibitor ...

8

Neuroprotective efficacy of nimesulide against hippocampal neuronal damage following transient forebrain ischemia

Neuroprotective efficacy of nimesulide against hippocampal neuronal damage following transient forebrain ischemia

... the selective cyclooxygenase-2 inhibitor nimesulide on delayed neuronal death of hippocampal CA1 neurons following transient global cerebral ischemia in ...that cyclooxygenase-2 ...

18

Tolerance to alternative cyclooxygenase-2 inhibitors in nonsteroidal anti-inflammatory drug hypersensitive patients

Tolerance to alternative cyclooxygenase-2 inhibitors in nonsteroidal anti-inflammatory drug hypersensitive patients

... non selective NSAID and onset of symptoms ...non selective NSAID hypersensitivity may consequently lead to a lower estimate of the percentage of COX-2 inhibitor ...

7

The role of cyclooxygenase inhibitors in lipopolysaccharide induced hypophagia in chicken

The role of cyclooxygenase inhibitors in lipopolysaccharide induced hypophagia in chicken

... that cyclooxygenase 1 (COX) enzyme has an important role in lipopoly- saccharide (LPS)-induced hypophagia in mammals but the effect of COX on LPS-induced hypophagia has not been studied in avian ...

9

Reduced Risk of Human Lung Cancer by Selective Cyclooxygenase 2 (Cox-2) Blockade: Results of a Case Control Study

Reduced Risk of Human Lung Cancer by Selective Cyclooxygenase 2 (Cox-2) Blockade: Results of a Case Control Study

... of selective cyclooxygenase-2 (COX-2) blocking agents and lung ...of 2:1 to the cases by age, gender, and county of ...of selective COX-2 inhibitors (primarily celecoxib ...

7

Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase 2

Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase 2

... Because there is circumstantial evidence linking COX-2 ex- pression to intestinal tumorigenesis, we set out to test the hy- pothesis that COX-2 is involved directly in intestinal tumor de- velopment. In ...

7

Post-ischaemic treatment with the cyclooxygenase-2 inhibitor nimesulide reduces blood-brain barrier disruption and leukocyte infiltration following transient focal cerebral ischaemia in rats

Post-ischaemic treatment with the cyclooxygenase-2 inhibitor nimesulide reduces blood-brain barrier disruption and leukocyte infiltration following transient focal cerebral ischaemia in rats

... cortex 24 h after stroke and diminished infarct size by 48 % with respect to vehicle-treated animals after 3 days of reperfusion. Furthermore, nimesulide significantly attenuated the blood-brain barrier (BBB) damage and ...

32

Cyclooxygenase 2 inhibitor celecoxib attenuates joint contracture following immobilization in rat knees

Cyclooxygenase 2 inhibitor celecoxib attenuates joint contracture following immobilization in rat knees

... Representative images of the posterior capsule of the knee joint in HE sections are shown in Fig. 5a-f. In the control group, the joint capsule was thin and densely stained. Infiltrated cells were scarcely seen ...

10

Metabolism of tocotrienols in animals and synergistic inhibitory actions of tocotrienols with atorvastatin in cancer cells

Metabolism of tocotrienols in animals and synergistic inhibitory actions of tocotrienols with atorvastatin in cancer cells

... supplemented with mixed T3s (20.2% a-T3, 4.0% b-T3, 16.1% c-T3, 9.9% d-T3, 14.8% a-tocopherol, and 3.1% c-tocopherol), d-, c-, and a-CEHCs and CMBHCs, as well as some new metabolites, were observed in HPLC chro- ...

8

Activation of Guanylate Cyclase-C With Heat-Stable Enterotoxin Fails to Potentiate Celecoxib-Induced Reduction in Colorectal Cancer Cell Growth in Vitro

Activation of Guanylate Cyclase-C With Heat-Stable Enterotoxin Fails to Potentiate Celecoxib-Induced Reduction in Colorectal Cancer Cell Growth in Vitro

... adenomatous polyps. In fact, a significant reason for the withdrawal of rofecoxib was that an increase in cardiovascular risks was observed during a study that was assessing the drug’s ability to prevent polyps (Zarghi ...

73

Use of Propolis in Cancer Research

Use of Propolis in Cancer Research

... Pérez et al. [52 evaluated the total antioxidant activity (TAA) of ethanolic extracts of propolis produced by Tetragonisca angustula from Mérida, Venezuela, through the radical cation ABTS. The TAA value was 190.6 ± 4.7 ...

22

What do we know about communicating risk? A brief review and suggestion for contextualising serious, but rare, risk, and the example of cox 2 selective and non selective NSAIDs

What do we know about communicating risk? A brief review and suggestion for contextualising serious, but rare, risk, and the example of cox 2 selective and non selective NSAIDs

... 'Everything is poison, there is poison in everything. Only the dose makes a thing not a poison.' Paracelsus might have been intrigued by the controversy that has arisen over the cardiovas- cular adverse effects that have ...

16

The novel combination of dual mTOR inhibitor AZD2014 and pan-PIM inhibitor AZD1208 inhibits growth in acute myeloid leukemia via HSF pathway suppression

The novel combination of dual mTOR inhibitor AZD2014 and pan-PIM inhibitor AZD1208 inhibits growth in acute myeloid leukemia via HSF pathway suppression

... protease inhibitor cocktail [Roche, Indianapolis, IN], and 1× phosphatase inhibitor cocktail I/II [Calbiochem, San Diego, CA]) and incubated for 30 min on ...

18

Calcium Antagonistic Activity of Biophytum Petersianum on Vascular Smooth Muscles of Wistar Rat

Calcium Antagonistic Activity of Biophytum Petersianum on Vascular Smooth Muscles of Wistar Rat

... Fig. 2. Effect of noradrenaline (1 µM) on rat thoracic aorta in Ca 2+ -free, high K + (60 mM) solution in absence (control) and presence of hydro-alcoholic extract of ...

5

Cyclooxygenase-2 inhibitor is a robust enhancer of anticancer agents against hepatocellular carcinoma multicellular spheroids

Cyclooxygenase-2 inhibitor is a robust enhancer of anticancer agents against hepatocellular carcinoma multicellular spheroids

... and gefitinib (Gefi; 5 µM) with or without celecoxib (cele; 21.8 µmol/l), the samples were collected. samples incubated with only celecoxib were obtained 48 hours after celecoxib administration. (A–C) immunoblots ...

11

Show all 10000 documents...

Related subjects